Chen DS - Search Results

1

Molecular pathways: next-generation immunotherapy--inhibiting programmed death-ligand 1 and programmed death-1.

Chen DS, Irving BA, Hodi FS. Chen DS, et al. Clin Cancer Res. 2012 Dec 15;18(24):6580-7. doi: 10.1158/1078-0432.CCR-12-1362. Epub 2012 Oct 19. Clin Cancer Res. 2012. PMID: 23087408

2

Detection and characterization of cellular immune responses using peptide-MHC microarrays.

Soen Y, Chen DS, Kraft DL, Davis MM, Brown PO. Soen Y, et al. Among authors: chen ds. PLoS Biol. 2003 Dec;1(3):E65. doi: 10.1371/journal.pbio.0000065. Epub 2003 Dec 22. PLoS Biol. 2003. PMID: 14691537 Free PMC article.

3

Cellular immunotherapy: antigen recognition is just the beginning.

Chen DS, Davis MM. Chen DS, et al. Springer Semin Immunopathol. 2005 Jun;27(1):119-27. doi: 10.1007/s00281-005-0200-z. Epub 2005 Apr 16. Springer Semin Immunopathol. 2005. PMID: 15834723 Review.

4

Molecular and functional analysis using live cell microarrays.

Chen DS, Davis MM. Chen DS, et al. Curr Opin Chem Biol. 2006 Feb;10(1):28-34. doi: 10.1016/j.cbpa.2006.01.001. Epub 2006 Jan 18. Curr Opin Chem Biol. 2006. PMID: 16413817 Review.

5

T cells use two directionally distinct pathways for cytokine secretion.

Huse M, Lillemeier BF, Kuhns MS, Chen DS, Davis MM. Huse M, et al. Among authors: chen ds. Nat Immunol. 2006 Mar;7(3):247-55. doi: 10.1038/ni1304. Epub 2006 Jan 29. Nat Immunol. 2006. PMID: 16444260

6

Molecular biomarker analyses using circulating tumor cells.

Punnoose EA, Atwal SK, Spoerke JM, Savage H, Pandita A, Yeh RF, Pirzkall A, Fine BM, Amler LC, Chen DS, Lackner MR. Punnoose EA, et al. Among authors: chen ds. PLoS One. 2010 Sep 8;5(9):e12517. doi: 10.1371/journal.pone.0012517. PLoS One. 2010. PMID: 20838621 Free PMC article.

7

Impact of exploratory biomarkers on the treatment effect of bevacizumab in metastatic breast cancer.

Jubb AM, Miller KD, Rugo HS, Harris AL, Chen D, Reimann JD, Cobleigh MA, Schmidt M, Langmuir VK, Hillan KJ, Chen DS, Koeppen H. Jubb AM, et al. Among authors: chen ds, chen d. Clin Cancer Res. 2011 Jan 15;17(2):372-81. doi: 10.1158/1078-0432.CCR-10-1791. Epub 2011 Jan 11. Clin Cancer Res. 2011. PMID: 21224365 Free PMC article.

8

Predictive impact of circulating vascular endothelial growth factor in four phase III trials evaluating bevacizumab.

Hegde PS, Jubb AM, Chen D, Li NF, Meng YG, Bernaards C, Elliott R, Scherer SJ, Chen DS. Hegde PS, et al. Among authors: chen ds, chen d. Clin Cancer Res. 2013 Feb 15;19(4):929-37. doi: 10.1158/1078-0432.CCR-12-2535. Epub 2012 Nov 20. Clin Cancer Res. 2013. PMID: 23169435

9

A systemic complete response of metastatic melanoma to local radiation and immunotherapy.

Hiniker SM, Chen DS, Reddy S, Chang DT, Jones JC, Mollick JA, Swetter SM, Knox SJ. Hiniker SM, et al. Among authors: chen ds. Transl Oncol. 2012 Dec;5(6):404-7. doi: 10.1593/tlo.12280. Epub 2012 Dec 1. Transl Oncol. 2012. PMID: 23323154 Free PMC article.

10

Identification and analysis of in vivo VEGF downstream markers link VEGF pathway activity with efficacy of anti-VEGF therapies.

Brauer MJ, Zhuang G, Schmidt M, Yao J, Wu X, Kaminker JS, Jurinka SS, Kolumam G, Chung AS, Jubb A, Modrusan Z, Ozawa T, James CD, Phillips H, Haley B, Tam RN, Clermont AC, Cheng JH, Yang SX, Swain SM, Chen D, Scherer SJ, Koeppen H, Yeh RF, Yue P, Stephan JP, Hegde P, Ferrara N, Singh M, Bais C. Brauer MJ, et al. Clin Cancer Res. 2013 Jul 1;19(13):3681-92. doi: 10.1158/1078-0432.CCR-12-3635. Epub 2013 May 17. Clin Cancer Res. 2013. PMID: 23685835

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results